Pieris Pharmaceuticals Inc (NASDAQ: PIRS) stock enjoyed a major increase of 11.4% on 1/6/25. The shares closed at $14.76. Moreover, this advance was accompanied by exceptionally high trading volume at 386% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 24.2% during the last week.
Current PriceTarget Research Rating
Pieris Pharmaceuticals has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Pieris Pharmaceuticals has a very low Appreciation Score of 1 but a good Power Rating of 81, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment